GLENMARK PHARMACEUTICALS
Back to All Ratios
|
GLENMARK PHARMACEUTICALS Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
CEPS(Rs) | -44.26 | 17.00 | 52.46 | 50.10 | 42.28 |
What is the latest Cash Earnings per Share (CEPS) ratio of GLENMARK PHARMACEUTICALS ?
Year | Cash Earnings per Share (CEPS) |
---|---|
Mar2024 | -44.26 |
Mar2023 | 17.00 |
Mar2022 | 52.46 |
Mar2021 | 50.10 |
Mar2020 | 42.28 |
How is Cash Earnings per Share (CEPS) of GLENMARK PHARMACEUTICALS Trending?
Years | Cash Earnings per Share (CEPS) | % Change | |
---|---|---|---|
Mar2024 | -44.26 | Negative | |
Mar2023 | 17 | -67.59 | |
Mar2022 | 52.46 | 4.71 | |
Mar2021 | 50.1 | 18.50 | |
Mar2020 | 42.28 | - |
Other Financial Ratios of GLENMARK PHARMACEUTICALS
Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹40,842.8 Cr | 4.8% | 5.2% | 40% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.9% | 1.8% | 14% | Stock Analytics | |
DIVIS LABORATORIES | ₹166,750.0 Cr | 5.7% | 9.6% | 58.6% | Stock Analytics | |
CIPLA | ₹121,122.0 Cr | -0.8% | 1.2% | 6.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,487.0 Cr | 0.8% | 1.2% | 25.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,680.0 Cr | 2.9% | 6.5% | 4.3% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | 4.8% |
5.2% |
40% |
SENSEX | 3.6% |
9.5% |
13.3% |
You may also like the below Video Courses